Cullinan Therapeutics Inc (CGEM)

Dec 21, 2024

State Street Corp Buys 396,034 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Dec 21, 2024

Dec 20, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Insider Sells $53,547.13 in Stock - MarketBeat

Dec 20, 2024

Dec 20, 2024

Cullinan Therapeutics' chief medical officer sells $52,851 in stock By Investing.com - Investing.com Australia

Dec 20, 2024

Dec 20, 2024

Cullinan Therapeutics chief scientific officer sells $53,547 in stock - Investing.com

Dec 20, 2024

Dec 20, 2024

Cullinan Therapeutics' chief medical officer sells $52,851 in stock - Investing.com India

Dec 20, 2024

Dec 20, 2024

Cullinan therapeutics chief legal officer sells $39,729 in stock - Investing.com India

Dec 20, 2024

Dec 20, 2024

Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Up 5.6%What's Next? - MarketBeat

Dec 20, 2024

Dec 20, 2024

Fmr LLC Purchases 19,681 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Dec 20, 2024

Dec 19, 2024

Franklin Resources Inc. Sells 252,868 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Dec 19, 2024

Dec 18, 2024

Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 4%Here's Why - MarketBeat

Dec 18, 2024

Dec 18, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.19 Million Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Dec 18, 2024

Dec 16, 2024

Insider Selling: Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Insider Sells 3,489 Shares of Stock - MarketBeat

Dec 16, 2024

Dec 16, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Increase in Short Interest - MarketBeat

Dec 16, 2024

Dec 16, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Bought by The Manufacturers Life Insurance Company - Defense World

Dec 16, 2024

Dec 12, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Dec 12, 2024

Dec 05, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Purchased by RTW Investments LP - MarketBeat

Dec 05, 2024

Dec 04, 2024

Patient Square Capital LP Acquires New Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Dec 04, 2024

Dec 03, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Bought by Holocene Advisors LP - MarketBeat

Dec 03, 2024

Dec 02, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Acquired by Walleye Capital LLC - MarketBeat

Dec 02, 2024

Nov 30, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Acquired by Braidwell LP - MarketBeat

Nov 30, 2024

Nov 28, 2024

Analysts Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Price Target at $31.67 - MarketBeat

Nov 28, 2024

Nov 28, 2024

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives $31.67 Average Target Price from Brokerages - MarketBeat

Nov 28, 2024

Nov 20, 2024

Cullinan Therapeutics Announces Q3 2024 Progress and Outlook - TipRanks

Nov 20, 2024

Nov 20, 2024

What is Leerink Partnrs' Forecast for CGEM FY2025 Earnings? - MarketBeat

Nov 20, 2024

Nov 15, 2024

Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 6.3%Time to Sell? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Blue Owl Capital Holdings LP Adjusts Stake in Cullinan Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

CGEMCullinan Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 15, 2024

Nov 15, 2024

Biotechnology Value Fund L.P. Expands Stake in Cullinan Therapeu - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Cullinan advances lupus treatment with new clinical trial By Investing.com - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Cullinan advances lupus treatment with new clinical trial - Investing.com

Nov 14, 2024

Nov 14, 2024

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024 - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager - The Bakersfield Californian

Nov 14, 2024

Nov 14, 2024

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024 - GlobeNewswire Inc.

Nov 14, 2024

Nov 08, 2024

Cullinan Therapeutics' chief scientific officer sells $125,120 in stock By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Cullinan Therapeutics' chief scientific officer sells $125,120 in stock - Investing.com India

Nov 08, 2024

Nov 08, 2024

Insider Sale: Chief Scientific Officer of Cullinan Therapeutics Inc (CGEM) Sells Shares - GuruFocus.com

Nov 08, 2024

Nov 07, 2024

Cullinan Therapeutics: Q3 Earnings Snapshot - Darien Times

Nov 07, 2024

Nov 07, 2024

Cullinan Therapeutics Inc (CGEM) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Cullinan Therapeutics Advances Pipeline Despite $40.6M Loss; Maintains $639M Cash Position | CGEM Stock News - StockTitan

Nov 07, 2024

Nov 05, 2024

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference - StockTitan

Nov 05, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Cullinan Therapeutics Inc - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

Cullinan Therapeutics to Present Preclinical Data for - GlobeNewswire

Nov 04, 2024

Nov 04, 2024

Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024 - StockTitan

Nov 04, 2024

Nov 03, 2024

Analysts Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Target Price at $31.67 - MarketBeat

Nov 03, 2024

Oct 30, 2024

FY2027 Earnings Forecast for CGEM Issued By Leerink Partnrs - MarketBeat

Oct 30, 2024

Oct 24, 2024

Cullinan Therapeutics (NASDAQ:CGEM) Receives New Coverage from Analysts at UBS Group - MarketBeat

Oct 24, 2024

Oct 22, 2024

Exchange Traded Concepts LLC Sells 2,961 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Oct 22, 2024

Oct 22, 2024

SG Americas Securities LLC Sells 70,115 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Oct 22, 2024